These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33983592)

  • 21. "Other" breast cancer susceptibility genes: searching for more holy grail.
    Nathanson KL; Weber BL
    Hum Mol Genet; 2001 Apr; 10(7):715-20. PubMed ID: 11257104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers.
    Cragun D; Weidner A; Tezak A; Clouse K; Pal T
    Breast Cancer Res Treat; 2020 Jul; 182(2):421-428. PubMed ID: 32445176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into breast cancer genetics and impact on patient management.
    Rosman DS; Kaklamani V; Pasche B
    Curr Treat Options Oncol; 2007 Feb; 8(1):61-73. PubMed ID: 17634833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
    Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
    Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer screening implications of risk modeling among female relatives of ATM and CHEK2 carriers.
    Weidner AE; Liggin ME; Zuniga BI; Tezak AL; Wiesner GL; Pal T
    Cancer; 2020 Apr; 126(8):1651-1655. PubMed ID: 31967672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for familial cancer risk: Focus on breast cancer.
    Rousset-Jablonski C; Gompel A
    Maturitas; 2017 Nov; 105():69-77. PubMed ID: 28818315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Breast cancer susceptibility genes].
    Díez O; Gutiérrez-Enríquez S; Ramón y Cajal T
    Med Clin (Barc); 2006 Mar; 126(8):304-10. PubMed ID: 16527158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management.
    Kleibl Z; Kristensen VN
    Breast; 2016 Aug; 28():136-44. PubMed ID: 27318168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry.
    Dumont M; Weber-Lassalle N; Joly-Beauparlant C; Ernst C; Droit A; Feng BJ; Dubois S; Collin-Deschesnes AC; Soucy P; Vallée M; Fournier F; Lemaçon A; Adank MA; Allen J; Altmüller J; Arnold N; Ausems MGEM; Berutti R; Bolla MK; Bull S; Carvalho S; Cornelissen S; Dufault MR; Dunning AM; Engel C; Gehrig A; Geurts-Giele WRR; Gieger C; Green J; Hackmann K; Helmy M; Hentschel J; Hogervorst FBL; Hollestelle A; Hooning MJ; Horváth J; Ikram MA; Kaulfuß S; Keeman R; Kuang D; Luccarini C; Maier W; Martens JWM; Niederacher D; Nürnberg P; Ott CE; Peters A; Pharoah PDP; Ramirez A; Ramser J; Riedel-Heller S; Schmidt G; Shah M; Scherer M; Stäbler A; Strom TM; Sutter C; Thiele H; van Asperen CJ; van der Kolk L; van der Luijt RB; Volk AE; Wagner M; Waisfisz Q; Wang Q; Wang-Gohrke S; Weber BHF; Genome Of The Netherlands Project ; Ghs Study Group ; Devilee P; Tavtigian S; Bader GD; Meindl A; Goldgar DE; Andrulis IL; Schmutzler RK; Easton DF; Schmidt MK; Hahnen E; Simard J
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction.
    Jones MR; Kamara D; Karlan BY; Pharoah PDP; Gayther SA
    Gynecol Oncol; 2017 Dec; 147(3):705-713. PubMed ID: 29054568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer gene discovery.
    Polyak K
    Expert Rev Mol Med; 2002 Aug; 4(18):1-18. PubMed ID: 14987381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding breast cancer risk -- where do we stand in 2005?
    Dumitrescu RG; Cotarla I
    J Cell Mol Med; 2005; 9(1):208-21. PubMed ID: 15784178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?
    Angeli D; Salvi S; Tedaldi G
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low penetrance genes associated with increased risk for breast cancer.
    Weber BL; Nathanson KL
    Eur J Cancer; 2000 Jun; 36(10):1193-9. PubMed ID: 10882856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for common genomic variants in the assessment of familial breast cancer.
    Sawyer S; Mitchell G; McKinley J; Chenevix-Trench G; Beesley J; Chen XQ; Bowtell D; Trainer AH; Harris M; Lindeman GJ; James PA
    J Clin Oncol; 2012 Dec; 30(35):4330-6. PubMed ID: 23109704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
    Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
    Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ability to predict breast cancer in Asian women using a polygenic susceptibility model.
    Hartman M; Suo C; Lim WY; Miao H; Teo YY; Chia KS
    Breast Cancer Res Treat; 2011 Jun; 127(3):805-12. PubMed ID: 21153878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility.
    Schutte M; Seal S; Barfoot R; Meijers-Heijboer H; Wasielewski M; Evans DG; Eccles D; Meijers C; Lohman F; Klijn J; van den Ouweland A; Futreal PA; Nathanson KL; Weber BL; Easton DF; Stratton MR; Rahman N;
    Am J Hum Genet; 2003 Apr; 72(4):1023-8. PubMed ID: 12610780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer.
    Aloraifi F; Boland MR; Green AJ; Geraghty JG
    Surg Oncol; 2015 Jun; 24(2):100-9. PubMed ID: 25936246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The clinical importance of a genetic analysis of moderate-risk cancer susceptibility genes in breast and other cancer patients from the Czech Republic].
    Pohlreich P; Kleibl Z; Kleiblová P; Janatová M; Soukupová J; Macháčková E; Házová J; Vašíčková P; Sťahlová Hrabincová E; Navrátilová M; Svoboda M; Foretová L
    Klin Onkol; 2012; 25 Suppl():S59-66. PubMed ID: 22920209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.